Navigation Links
Express Scripts in Binding Agreement with MSC for the Purchase of its Pharmacy Services Division
Date:6/13/2008

JACKSONVILLE, Fla., June 13 /PRNewswire/-- Express Scripts has entered into a binding agreement to purchase the Pharmacy Services Division of MSC -- Medical Services Company. MSC, which previously consisted of two distinct units -- pharmacy and ancillary -- will retain the MSC brand and all employees, products and services not associated with the pharmacy division.

Express Scripts, Inc. (Nasdaq: ESRX) is one of the largest PBM companies in North America, providing PBM services to thousands of client groups, including managed-care organizations, insurance carriers, employers, third-party administrators, public sector, workers' compensation, and union-sponsored benefit plans. MSC, a leading service provider in workers' compensation, will now focus solely on its ancillary business and enhance its capabilities and technologies in that growing market. The company has four ancillary business lines: Durable Medical Equipment, Home Health Nursing Services, Translation / Transportation and Imaging Services.

"Both our pharmacy and ancillary customers should benefit greatly from this agreement," said Joe Delaney, MSC's President and CEO. "For our pharmacy customers, this deal will combine the best practices of MSC and Express Scripts, both of which have a strong reputation for providing high quality PBM service to workers' compensation clients. For our ancillary customers, this deal enables MSC to put greater focus and investment in the ancillary market, which has very different needs and is vastly under-penetrated from a network perspective."

"Express Scripts sees tremendous value in our Pharmacy Services division because of our reputation for developing innovative technologies tailored to the needs of workers' compensation clients, our high-touch customer service model and our advanced clinical skills," said Mitch Freeman, President of MSC's Pharmacy Services Division.

George Paz, Express Scripts chairman & chief executive officer, added "Express Scripts has a long history of offering PBM services to workers' compensation providers, and the addition of MSC will enhance our leadership in using proven PBM cost-management tools to drive down costs and improve health outcomes. Through our commitment to and capabilities in this arena, we will continue to provide the high level of service and clinical expertise required in workers' compensation."

MSC's pharmacy and ancillary divisions have historically been managed by two separate teams, have operated as individual business units and are well prepared for a seamless transition. To reinforce this continuity of service, MSC and Express Scripts have entered into a cooperative marketing agreement, which ensures ongoing collaboration and communication to meet the shared future needs and opportunities of their respective businesses.

About MSC - Medical Services Company

MSC provides medical products and services to workers' compensation clients. The company's customers include the nation's leading workers' compensation insurers, third-party administrators and self-insured employers. MSC's focus on the specific dynamics of the workers' compensation allows the company to provide market-leading cost containment solutions for its customers. MSC's ancillary services are organized in four distinct business lines: Durable Medical Equipment, Home Health Nursing Services, Translation / Transportation and Imaging Services. MSC is headquartered in Jacksonville, Fla. For more information, visit http://www.YourMSC.com .

About Express Scripts

Express Scripts, Inc. (Nasdaq: ESRX) is one of the largest PBM companies in North America, providing PBM services to thousands of client groups, including managed-care organizations, insurance carriers, employers, third-party administrators, public sector, workers' compensation, and union-sponsored benefit plans. Express Scripts is headquartered in St. Louis, Missouri. More information can be found at http://www.express-scripts.com .

Statements contained in this release, which are not historical facts, may be considered forward-looking statements as defined in the Private Litigation Reform Act of 1995. Such forward-looking statements are subject to risks and uncertainties which could cause actual results to differ materially from those currently anticipated due to a number of factors which include without limitation the effects of future economic conditions, governmental fiscal and monetary policies, legislative and regulatory changes, changes in the interest rates, the effects of competition, and other factors that could cause actual results to differ materially as discussed further in documents filed by Express Scripts and MSC with the SEC from time to time.


'/>"/>
SOURCE Medical Services Company
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Authentidate and EncounterCare Form ExpressMD Solutions Joint Venture to Provide Telehealth Vital Signs Monitoring Systems Designed to Improve Chronic Illness Care for Patients
2. MicroRNA controls expression of oncogenes
3. Expressing feelings after trauma not necessary, research shows
4. Pennsylvania Attorney General Corbett Announces Multi-State Settlement With Express Scripts Inc.
5. South Bay Asian and Pacific Islander Community Plans Express ARTself for the 4th Annual National Asian & Pacific Islander HIV/AIDS Awareness Day
6. TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients with Diabetes Compared to Non-Diabetics in ARRIVE Registry Program
7. Scientists identify key roadblock to gene expression
8. Fleeting Facial Expressions Reveal Deep Secrets
9. National Restaurant Association Expresses Disappointment About Court Ruling on Menu Labeling in New York City
10. People with Epilepsy Encouraged to Submit Artwork as Part of National Expressions of Courage(R) Art Contest
11. 4,000 Women Attempt New World Record at 2008 Lady of America/Ladies Workout Express Ab Crunch Challenge
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... The Radiology Business Management Association (RBMA) ... 2017-2018. The annual board election process has been in place since the RBMA was ... C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, FRBMA, as president. Dr. Dickerson ...
(Date:4/28/2017)... ... April 28, 2017 , ... The Texas Cord Blood Bank (TCBB), a ... and delivery team at Women’s Hospital at Renaissance in Edinburg for their outstanding efforts ... hospital and decide to donate. , “Women’s Hospital at Renaissance has been a ...
(Date:4/28/2017)... , ... April 28, 2017 , ... People are starting ... people. “Wearing a hearing aid doesn’t have the stigma it had when great-grandpa wore ... Associates of Greater Boston, in a NALA North American Speaker Series (NASS) ...
(Date:4/28/2017)... Pensacola, FL (PRWEB) , ... April 28, 2017 ... ... Tampa, Florida are conducting a pilot study of ActiGraph’s CentrePoint Data ... ActiGraph is a leading provider of clinical-grade wearable activity and sleep monitoring solutions ...
(Date:4/28/2017)... York (PRWEB) , ... April 28, 2017 , ... ... anti-aging skincare and advanced nutraceutical supplements, through its Nova Skin Sciences division, ... the hydrating benefits of a moisturizer with the power of an anti-aging concentrate. ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  Cogentix Medical, Inc. ... on providing the Urology, Uro/Gyn and Gynecology markets ... Ash Keswani has joined the Company as Senior ... newly created position, Mr. Keswani will report directly ... "Our organization is delighted that Ash ...
(Date:4/20/2017)... MARLBOROUGH, Mass. , April 20, 2017 /PRNewswire/ ... company developing innovative therapeutics that address significant unmet ... new data from the Company,s consumer product development ... technology, at the Society for Investigative Dermatology (SID) ... is to advance and promote the sciences relevant ...
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
Breaking Medicine Technology: